Since establishment of the ATTC network in 2018, it has demonstrated impact across six core areas through industry led innovative solutions.

With new funding awarded in 2024, the network will continue to deliver high quality initiatives that aim to positively impact these areas.

  • Equity of access to transformative therapies
  • Improved NHS readiness for ATMP clinical trials
  • Improved ATMP workforce efficiency
  • The UK’s attractiveness to sponsors launching ATMP clinical trials
  • Growth in the industry employment and investment in the UK
  • Economic growth in levelling up priority locations in the UK
  • Societal benefits from patients treated with ATMPs
  • The number of ATMPs approved for use by NHS

Impact that the ATTC network has already delivered is highlighted below

  • 1. Commercial growth and attractiveness

    • The ATTC network has improved the UK’s global reputation for ATMP supply and adoption, attracting greater inwards investment to grow the UK ATMP pipeline.

    Commercial Growth
  • 2. Engagement and collaboration

    • The ATTC network, as the final segment in the supportive UK ecosystem for ATMP, has facilitated diverse collaboration across stakeholder groups.

  • 3. Leader in international standards and best practices

    • The network’s focus on standardisation, covering the entire ATMP supply pathway, has cemented the UK’s international reputation and promotion of global best practice.

  • 4. Clinical trials and patient access

    • Patient access to ATMPs has increased as a result of ATTC trial support, increasing the attractiveness of the UK for the conduct of clinical trials.

  • 5. Manufacturing, supply chain and logistics

    • ATTC network improvements to supply chain and logistics processes have increased patient access to ATMPs and made the UK more attractive to manufacturers.

  • 6. Education and workforce

    • The ATTC network has played a huge role in upskilling the UK ATMP workforce and has created multiple educational resources to support UK institutions in ATMP delivery.

View the full Impact Report

The ATTC network is drawing our attention to the UK as a potentially preferred country in which to perform clinical trials.

AstraZeneca

The ATTC network is an exemplar for how industry can collaborate with the NHS and service providers to support delivery of care to patients.

Autolus

I believe the ATTC network is an essential bridge for the NHS to work directly with industry to accelerate adoption of highly complex products.

Leeds Teaching Hospitals NHS Trust

Find out more about the work of the ATTC network here:

About Us

Network Activities